Organization · Venture Capital
Visionary Venture Fund
Visionary Venture Fund is a venture capital firm based in Newport Beach, California, specializing in investments in emerging companies within the ophthalmology and medical aesthetics sectors.
Overview
What Visionary Venture Fund does
What Visionary Venture Fund is
Visionary Venture Fund is a venture capital firm based in Newport Beach, California, specializing in investments in emerging companies within the ophthalmology and medical aesthetics sectors.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- March 18, 2026
Official channels
Find Visionary Venture Fund elsewhere
Open the official website or a supported primary organization account.
Capability profile
Visionary Venture Fund as a funder
Investment thesis
Visionary Venture Fund focuses on investing in life sciences, particularly in ophthalmology and medical aesthetics, to connect capital with innovative startups addressing unmet market needs.
Focus narrative
The fund invests in companies that tackle unmet or underserved markets within ophthalmology and medical aesthetics. Visionary Venture Fund typically targets investments ranging from $5 million to $15 million, focusing on companies from Series A to commercialization.
Value beyond capital
Visionary Venture Fund enhances its portfolio companies' success by leveraging partnerships with Key Opinion Leaders (KOLs) and industry experts, which aids in informed decision-making and risk reduction.
Terms and economics
- Typical check
- $5,000,000–$15,000,000
Focus and fit
- Stages
- Series A · Growth Equity
- Sectors
- Biotech · Healthcare · Medical Devices
- Regions
- United States
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 12
Portfolio context
Notable portfolio companies include: Aurion Biotech: Developing regenerative therapies for corneal edema. Centricity Vision: Creator of Zepto, a precision pulse device for capsulotomy. CorneaGen: Provides high-quality donor tissue for corneal disease treatment. IanTech: Develops minimally invasive devices for cataract treatment. ONL Therapeutics: Focuses on therapeutics for retinal diseases. Orasis: Aims to address presbyopia with a first-in-class ophthalmic formulation. Pelage Pharmaceuticals: Developing a therapeutic for hair growth. Re-Vana Therapeutics: Works on sustained release ophthalmic therapeutics for retinal diseases. RxSight: Innovates intraocular lens technology for cataract surgery. Tarsus Pharmaceuticals: Focused on treatments for ophthalmic conditions, including Demodex blepharitis. Tear Film Innovations: Develops treatments for Meibomian Gland Dysfunction. TearClear: Aims to improve topical medication delivery for ocular conditions.
Common questions
What to know about Visionary Venture Fund
Upseed classifies Visionary Venture Fund under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 18, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.